Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas

Cell Reports(2020)10.1016/j.celrep.2020.108196Source: DataRank Database

Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (29)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jing Ni ORCID,J Ricardo McFaline-Figueroa ORCID,Yanzhi Wang ORCID,Roderick T. Bronson ORCID,Keith L. Ligon ORCID

Live enrichment

PubMed:32997991 PMC:PMC7571617

National Institutes of Health

Grant: K12CA090354

National Institutes of Health

Grant: R35 CA210057

National Institutes of Health

Grant: R35 CA231945

National Institutes of Health

Grant: P01 CA142536

National Institutes of Health

Grant: R01 CA233810

National Institutes of Health

Grant: P50 CA165962

NCI NIH HHS

Grant: P50 CA168504

NCI NIH HHS

Grant: T32 CA236754

National Institutes of Health

Grant: 1R01CA233810-01

Molecular mechanisms and therapeutic targeting of PI3K-p110beta/PTEN signaling in breast cancer and cancer immunity

National Institutes of Health

Grant: 5R35CA210057-03

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

National Institutes of Health

Grant: 4P50CA165962-04

SPORE: Targeted Therapies for Glioma

National Institutes of Health

Grant: 5R35CA231945-02

Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers

National Institutes of Health

Grant: 5P01CA142536-05

Therapeutic Opportunities for Pediatric Astrocytoma

National Institutes of Health

Grant: 2K12CA090354-21

Training Program in Nervous System Tumors

National Brain Tumor Society

goldLicense: CC BY NC ND

publisherhttps://doi.org/10.1016/j.celrep.2020.108196

publisherhttps://api.elsevier.com/content/article/PII:S2211124720311852?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720311852?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13101044/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7571617

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMiceGlioblastomaProtein IsoformsMalePTEN PhosphohydrolasePhosphatidylinositol 3-Kinases

Keywords

MigrationPTENGlioblastomaPdxBkm120Isoform-selective InhibitorGemmByl719Pten-deficientPi3k IsoformMaleMicePhosphatidylinositol 3-KinasesPTEN PhosphohydrolaseAnimalsHumansProtein IsoformsArticle